FOI release

Inspection reports

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00755

Received 13 July 2026

Published 7 September 2026

Request

Many thanks for your response and for confirming the status of my request. I am grateful for your compromise for me to limit my request to five (5) PV inspection reports. After reviewing the line listing you provided, I would like to receive the following inspection reports: 1. Pfizer 2. MSD 3. Bayer 4. Organon 5. Advanz Pharma

Response

See attached

Documents

• 2025-02-Advanz Pharma-MHRA_IR-CAPA_1_Redacted Final.pdf (613.1 KB)
• 2025-03-Organon-MHRA_IR-CAPA_1_Redacted Final.pdf (6.7 MB)
• 2025-09-MSD-MHRA_IR-CAPA_1_Redacted Final.pdf (1.4 MB)
• 2025-09-Pfizer-MHRA_IR_CAPA_Redacted Final.pdf (892.8 KB)
• 2025-11-Bayer-MHRA_IR-CAPA_1_Redacted Final.pdf (8.8 MB)
• FOI2026_00755 (redacted).pdf (857.2 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.